Medicines in the GLP-1 receptor agonist class, including semaglutide, have been associated with pancreatitis and gallbladder problems
Primary purpose Peptide Therapy: Enhances specific processes such as repair, fat loss, or natural GH release (depending on the peptide)
BPC-157 in the regeneration and protection of the musculoskeletal system The BPC-157 peptide allows for twice as fast healing of a broken bone
The report was uncontrolled, unblinded, not randomized, had no comparator arm, used patient-reported outcomes rather than validated pain instruments, and did not publish dose, effect size, confidence intervals, p-values, or systematically collected adverse events limitations that severely constrain any clinical inference